Large-scale early in vitro response to actinobocillus actinomycetemcomitans suggests superantigenic activation of t-cells

Journal of Dental Research

Volumn 80, Issue 1, 2001, Pages 356-362

  Zadeh, H H ^a   Nalbant, A ^a   Park, K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Actinobacillus actinomycetemcomitans; CD69; Periodontitis; Superantigens; T cell activation; T lymphocytes; V

Indexed keywords

BACTERIAL ANTIGEN; CD3 ANTIGEN; CD69 ANTIGEN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; SUPERANTIGEN; T LYMPHOCYTE ANTIGEN;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIGEN PRESENTING CELL; ARTICLE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS;

EID: 0034981124     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/00220345010800011101     Document Type: Article

References (45)

1. Ashimoto A, Chen C, Bakker I, Slots J (1996). Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 11:266-273.
2. Ashkenazi M, White RR, Dennison DK (1992). Neutrophil modulation by Actinobacillus actinomycetemcomitans. I. Chemotaxis, surface receptor expression and F-actin polymerization. J Periodontal Res 27:264-273.
3. Baehni P, Tsai CC, McArthur WP, Hammond BF, Taichman NS (1979). Interaction of inflammatory cells and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived Gram-negative microorganism. Infect Immun 24:233-243.
4. Berglundh T, Liljenberg B, Tarkowski A, Lindhe J (1998). Local and systemic TCR V gene expression in advanced periodontal disease. J Clin Periodontol 25:125-133.
5. Bick PH, Carpenter AB, Holdeman L, Miller G, Ranney R, Palcanis K, et al. (1981). Polyclonal B-cell activation induced by extracts of Gram-negative bacteria isolated from periodontally diseased sites. Infect Immun 34:43-49.
6. Böyum A (1968). Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 97 (Suppl):77-89.
7. Cantor H, Crump AL, Raman V, Liu H, Markowitz J, Grusby M, et al. (1993). Immunoregulatory effects of superantigens: Interactions of staphylococcal enterotoxins with host MHC and non-MHC products. Immunolog Rev 131:27-42.
8. Carpenter AB, Sully EC, Ranney RR, Bick PH (1984). T-cell regulation of polyclonal B-cell activation induced by extracts of oral bacteria associated with periodontal diseases. Infect Immun 43:326-336.
9. Donaldson SL, Bick PH, Moore W, Ranney R, Burmeister J, Tew J (1982). Polyclonal B-cell activating capacities of Gram-positive bacteria frequently isolated from periodontally diseased sites. J Periodontal Res 17:569-575.
10. Gemmell E, Marshall RI, Seymour GJ (1997). Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 14:112-143.
11. Getka TP, Alexander DC, Parker WB, Miller GA (1996). Immunomodulatory and superantigen activities of bacteria associated with adult periodontitis. J Periodontol 67:909-917.
12. Helgeland K, Nordby O (1993). Cell cycle-specific growth inhibitory effect on human gingival fibroblasts of a toxin isolated from the culture medium of Actinobacillus actinomycetemcomitans. J Periodontal Res 28:161-165.
13. + antigen-presenting cells. Internatl Immunol 4:1381-1388.
14. Karimzadeh K, Morrison J, Zadeh HH (1999). Comparison of gingival and peripheral blood T-cells among patients with periodontitis suggests skewing of the gingival T-cell antigen receptor Vβ repertoire. J Periodontal Res 34:445-456.
15. Kiley P, Holt SC (1980). Characterization of the lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4 and N27. Infect Immun 30:862-873.
16. Kurita-Ochiai T, Ochiai K (1996). Immunosuppressive factor from Actinobacillus actinomycetemcomitans down regulates cytokine production. Infect Immun 64:50-54.
17. Lavoie PM, Thibodeau J, Erard F, Sekaly RP (1999). Understanding the mechanism of action of bacterial superantigens from a decade of research. Immunol Rev 168:257-269.
18. Lussow AR, MacDonald HR (1994). Differential effects of superantigen-induced "anergy" on priming and effector stages of a T-cell-dependent antibody response. Eur J Immunol 24:445-449.
19. Mahanonda R, Seymour GJ, Powell LW, Good MF, Halliday JW (1991). Effect of initial treatment of chronic inflammatory periodontal disease on the frequency of peripheral blood T-lymphocytes specific to periodontopathic bacteria. Oral Microbiol Immunol 6:221-227.
20. Maino V, Suni M, Ruitenberg J (1995). Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 20:127-133.
21. Meghji S, Wilson M, Henderson B, Kinane D (1992). Antiproliferative and cytotoxic activity of surface-associated material from periodontopathogenic bacteria. Arch Oral Biol 37:637-644.
22. Nakajima T, Yamazaki K, Kara K (1996). Biased T-cell receptor V gene usage in tissues with periodontal disease. J Periodontal Res 31:2-10.
23. Nakajima T, Yamazaki K, Cullinan MP, Gemmell E, Seymour GJ (1999). T-cell antigen specificity in humans following stimulation with Porphyromonas gingivalis. Arch Oral Biol 44:1045-1053.
24. Nalbant A, Zadeh HH (2000). Evidence for apoptosis of the majority of T-cells activated in vitro with Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 15:290-298.
25. Ohguchi M, Ishisaki A, Okahashi N, Koide M, Koseki T, Yamato K, et al. (1998). Actinobacillus actinomycetemcomitans toxin induces both cell cycle arrest in the G2/M phase and apoptosis. Infect Immun 66:5980-5987.
26. Petit M, Stashenko P (1996). Extracts of periodontopathic microorganisms lack functional superantigenic activity for murine T-cells. J Periodont Res 31:517-524.
27. Pullen AM, Wade T, Marrack P, Kappler JW (1990). Identification of the region of T-cell receptor beta chain that interacts with the self-superantigen Mis-1a. Cell 61:1365-1374.
28. Raber-Durlacher JE, Zeijlemaker W, Meinesz A, Abraham-Inpijn L (1990). Stimulation of lymphocytes in vitro by Bacteroides intermedius and Bacteroides (Porphyromonas) gingivalis sonicates. J Periodontol 61:217-223.
29. Robertson PB, Lantz M, Marucha PT, Kornman KS, Trummel CL, Holt SC (1982). Collagenolytic activity associated with Bacteroides species and Actinobacillus actinomycetemcomitans. J Periodontal Res 17:275-283.
30. Rowen L, Koop BF, Hood L (1996). The complete 685-kilobase DNA sequence of the human T-cell receptor locus. Science 272:1755-1762.
31. Schlievert PM (1993). Role of superantigens in human disease. J Infect Dis 167:997-1002.
32. Shenker B, McArthur W, Tsai C (1982). Immune suppression induced by Actinobacillus actinomycetemcomitans. I. Effects on human peripheral blood lymphocyte responses to mitogens and antigens. J Immunol 128:148-154.
33. Shenker BJ, Vitale LA, Welham DA (1990). Immune suppression induced by Actinobacillus actinomycetemcomitans: Effects on immunoglobulin production by human B cells. Infect Immun 58:3856-3862.
34. Shenker BJ, McKay T, Datar S, Miller M, Chowhan R, Demuth D (1999). Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T-cells. JImmunol 162:4773-4780.
35. Slots J, Ting M (1999). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: Occurrence and treatment. Periodontol 2000 20:82-121.
36. Stuart PM, Woodward JG (1992). Yersinia enterocolitica produces superantigenic activity. J Immunol 148:225-229.
37. Tew J, Engel D, Mangan D (1989). Polyclonal B-cell activation in periodontitis. J Periodontal Res 24:225-241.
38. Van Dyke TE, Bartholomew E, Genco RJ, Slots J, Levine MJ (1982). Inhibition of neutrophil chemotaxis by soluble bacterial products. J Periodontol 53:502-508.
39. van Winkelhoff AJ, Slots J (1999). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol 2000 20:122-135.
40. Yamazaki K, Nakajima T, Gemmell E, Kjeldsen M, Seymour GJ, Hara K (1996). Biased expression of T-cell receptor V beta genes in periodontitis patients. Clin Exp Immunol 106:329-335.
41. Yuh K, Siminovitch KA, Ochi A (1993). T-cell anergy is programmed early after exposure to bacterial superantigen in vivo. Internall Immunol 5:1375-1382.
42. Zadeh HH, Kreutzer D (1996). Evidence for involvement of superantigens in human periodontal diseases: Skewed expression of T-cell receptor variable regions by gingival T-cells. Oral Microbiol Immunol 11:88-95.
43. Zadeh HH, Nichols FC, Miyasaki KT (1999). The role of the T-cell-mediated immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis. Periodontol 2000 20:239-288.
44. Zadeh HH, Tanavoli S, Haines DD, Kreutzer DL (2000). Despite large-scale T-cell activation, only a minor subset of T-cells responding in vitro to Actinobacillus actinomycetemcomitans differentiate into effector T-cells. J Periodontal Res 35:127-136.
45. Ziegler S, Ramsdell F, Alderson M (1994). The activation antigen CD69.Stem Cells 12:456-465.